Viktor Magdolen

14PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.

|Jan 10, 2026
Drug Discovery Strategies for Kallikrein-Related Peptidases.

Tobias Dreyer, Daniela Schuster, Viktor Magdolen

|Oct 27, 2022
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression.

Yueyang Liu, Weiwei Gong, Sarah Preis

|Jan 11, 2022
tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression.

Konstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn

|Dec 15, 2021
Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells.

Susanne Soelch, Nathalie Beaufort, Daniela Loessner

|Aug 27, 2021
Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma.

Juliana B Candido, Oscar Maiques, Melanie Boxberg

Pageof 3

Frequent Collaborators

5 joint publications

Tobias F Dreyer

3 joint publications

Marion Kiechle

1 joint publications

Brian W-C Tse

1 joint publications

Thomas Kryza